- Home
- FBIZ vs TNGX Comparison
FBIZ vs TNGX Comparison
Compare FBIZ & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIZ
- TNGX
- Stock Information
- Founded
- FBIZ 1909
- TNGX 2014
- Country
- FBIZ United States
- TNGX United States
- Employees
- FBIZ N/A
- TNGX N/A
- Industry
- FBIZ Major Banks
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- FBIZ Finance
- TNGX Health Care
- Exchange
- FBIZ Nasdaq
- TNGX Nasdaq
- Market Cap
- FBIZ 404.0M
- TNGX 413.6M
- IPO Year
- FBIZ N/A
- TNGX N/A
- Fundamental
- Price
- FBIZ $50.60
- TNGX $3.62
- Analyst Decision
- FBIZ Strong Buy
- TNGX Strong Buy
- Analyst Count
- FBIZ 4
- TNGX 8
- Target Price
- FBIZ $50.00
- TNGX $13.14
- AVG Volume (30 Days)
- FBIZ 27.6K
- TNGX 3.3M
- Earning Date
- FBIZ 10-24-2024
- TNGX 11-06-2024
- Dividend Yield
- FBIZ 2.01%
- TNGX N/A
- EPS Growth
- FBIZ 6.29
- TNGX N/A
- EPS
- FBIZ 4.64
- TNGX N/A
- Revenue
- FBIZ $140,240,000.00
- TNGX $43,383,000.00
- Revenue This Year
- FBIZ N/A
- TNGX $25.55
- Revenue Next Year
- FBIZ $8.01
- TNGX N/A
- P/E Ratio
- FBIZ $10.76
- TNGX N/A
- Revenue Growth
- FBIZ 3.59
- TNGX 15.67
- 52 Week Low
- FBIZ $32.56
- TNGX $2.70
- 52 Week High
- FBIZ $51.92
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- FBIZ 60.66
- TNGX 38.80
- Support Level
- FBIZ $48.30
- TNGX $3.54
- Resistance Level
- FBIZ $51.92
- TNGX $4.14
- Average True Range (ATR)
- FBIZ 1.32
- TNGX 0.47
- MACD
- FBIZ 0.19
- TNGX 0.14
- Stochastic Oscillator
- FBIZ 77.56
- TNGX 52.79
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, focusing on delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.